from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2432c/-

LFCtreatmentdescriptionclass of inhibitor

1.805

Amikacinug/mL Amikacintranslation

2.522

Cap5-10ug/mL Capreomycintranslation

2.246

Rox10-50 ug/mL Roxithromycintranslation

0.768

SM2-5 ug/mL Streptomycintranslation

1.931

Tet5-10 ug/mL Tetracyclinetranslation

-1.520

Rif0.2-5ug/mL Rifampicintranscription

0.477

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.069

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.708

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.167

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.052

Clofazimine10-13 ug/mL Clofaziminerespiration

0.620

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.342

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.523

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.347

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.395

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.110

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.239

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.611

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.118

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.623

KCN5-20 ug/mL Potassium cyaniderespiration

0.184

NaN30.2-2 mM Sodium aziderespiration

0.245

Nigericin50 uM Nigericinrespiration

-0.431

TRC10-150 ug/mL Triclosanrespiration

-0.490

TRZ10-25 ug/mL Thioridazinerespiration

2.143

Valinomycin0.5-10 uM Valinomycinrespiration

0.119

ZnSO42 mM ZnSO4respiration

-0.479

menadione6-10 ug/mL Menadionerespiration

-0.224

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.212

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.340

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.386

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.012

NRP_1Non-replicating persistence stage 1dosRassociated

-0.499

Amp0.2mg/mL AmpicillincellWall

0.122

Cephalexin20-100 ug/mL CephalexincellWall

0.780

Cerulenin0.32-5 ug/mL CerulenincellWall

-2.400

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.976

EMB10-20 ug/mL EthambutolcellWall

0.793

Eta12-40 ug/mL EthionamidecellWall

0.361

INH0.2-0.4 ug/mL IsoniazidcellWall

0.153

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.413

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.100

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.228

BZA0.12 mg/mL BenzamidearomaticAmides

-0.197

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.071

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.235

H2O24 mM hydrogen peroxideDNAdamaging

0.321

Levo10 ug/mL LevofloxacinDNAdamaging

0.032

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.474

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.579

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.288

UVUV-irradiationDNAdamaging

-0.673

ARP41-4 ug/mL Antitubercular compound ARP4?

0.064

Antimycin12.5-50 ug/mL Antimycin A?

-0.173

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.576

PA_110-50 ug/mL Antitubercular compound PA-1?

0.547

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.014

PA8240.2-2 ug/mL PA-824?

1.093

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.417

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.471

Verapamil50 uM Verapamil?

0.479

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.208

methoxatin10-20 ug/mL Methoxatin?